EIA
GILD icon

Eastover Investment Advisors’s Gilead Sciences GILD Stock Holding History

Eastover Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,875
Closed -$405K – 47
2021
Q2 		$405K Sell
5,875
-1,345
-19% -$89.8K 0.26% 40
2021
Q1 		$467K Sell
7,220
-1,405
-16% -$90.6K 0.33% 39
2020
Q4 		$502K Sell
8,625
-340
-4% -$20.5K 0.35% 40
2020
Q3 		$566K Sell
8,965
-528
-6% -$36.6K 0.43% 36
2020
Q2 		$730K Hold
9,493
– – 0.6% 34
2020
Q1 		$710K Buy
+9,493
New +$656K 0.69% 34

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eastover Investment Advisors's GILD Position: Q3 2021 in Review

Eastover Investment Advisors sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 5,875 shares — an estimated $405K sold.

Eastover Investment Advisors first reported a position in GILD in Q1 2020 and held it in 6 quarters. The position peaked at $730K in Q2 2020. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • Eastover Investment Advisors reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
  • Eastover Investment Advisors sold 5,875 Gilead Sciences shares in Q3 2021, an estimated $405K.
  • Eastover Investment Advisors first reported a position in Gilead Sciences in Q1 2020 and held it in 6 quarters.
  • Eastover Investment Advisors's Gilead Sciences position peaked at $730K in Q2 2020.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Eastover Investment Advisors's 13F filing for Q3 2021, filed 12 Oct 2021.